Sino-Argi Leading Biosciences (603970) — Free Cash Flow Generation Index
Sino-Argi Leading Biosciences (603970) has a Free Cash Flow Generation Index of 1.00x as of December 2024. Free cash flow of CN¥700.89 Million represents 1% of operating cash flow (CN¥702.54 Million). Read 603970 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sino-Argi Leading Biosciences Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Sino-Argi Leading Biosciences across 10 annual periods. Explore 603970 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year Free Cash Flow Generation Index for Sino-Argi Leading Biosciences. For the full company profile including market capitalisation, see Sino-Argi Leading Biosciences (603970) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.99x | CN¥305.21 Million | CN¥307.40 Million | CN¥2.18 Million | ▼ -0.5% |
| 2022 | 1.00x | CN¥1.53 Billion | CN¥1.54 Billion | CN¥3.44 Million | ▲ +1.0% |
| 2021 | 0.99x | CN¥321.43 Million | CN¥325.42 Million | CN¥3.99 Million | ▲ +3.2% |
| 2020 | 0.96x | CN¥337.13 Million | CN¥352.12 Million | CN¥14.99 Million | ▼ -3.1% |
| 2019 | 0.99x | CN¥216.23 Million | CN¥218.90 Million | CN¥2.67 Million | ▲ +14.4% |
| 2018 | 0.86x | CN¥56.70 Million | CN¥65.69 Million | CN¥8.99 Million | ▼ -3.4% |
| 2017 | 0.89x | CN¥463.44 Million | CN¥518.83 Million | CN¥55.39 Million | ▲ +17.9% |
| 2016 | 0.76x | CN¥115.37 Million | CN¥152.22 Million | CN¥36.85 Million | ▼ -10.5% |
| 2014 | 0.85x | CN¥34.24 Million | CN¥40.41 Million | CN¥6.17 Million | ▼ -13.9% |
| 2012 | 0.98x | CN¥107.70 Million | CN¥109.43 Million | CN¥1.74 Million | — |